Advantage Alpha Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$273K	Sell	12,643 -2,958	-19%	-$63.8K	0.07%	111
2025 Q1	$259K	Buy	15,601 +5,402	+53%	+$89.7K	0.06%	105
2024 Q4	$187K	Sell	10,199 -14,715	-59%	-$270K	0.04%	146
2024 Q3	$383K	Sell	24,914 -13,160	-35%	-$202K	0.09%	151
2024 Q2	$619K	Buy	+38,074	New	+$619K	0.14%	95